CC
SRPT icon

Centiva Capital’s Sarepta Therapeutics SRPT Stock Holding History

Centiva Capital’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-149
Closed -$14.4K – 2269
2023
Q4 		$14.4K Buy
+149
New +$14.3K ﹤0.01% 1682
2023
Q3 		– Hold
0
– – – 2102
2023
Q1 		– Sell
-1,930
Closed -$250K – 1859
2022
Q4 		$250K Buy
1,930
+1,630
+543% +$189K 0.02% 1029
2022
Q3 		$33K Buy
+300
New +$30.2K ﹤0.01% 1352
2020
Q3 		– Sell
-1,282
Closed -$206K – 889
2020
Q2 		$206K Buy
+1,282
New +$174K 0.05% 522
2019
Q4 		– Sell
-6,184
Closed -$466K – 945
2019
Q3 		$466K Buy
+6,184
New +$730K 0.1% 351

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return